The Medicare Part D drug benefit could save seniors more money than reimported medications, according to an AARP analysis using information from the Medicare Rx plan finder tool. However, AARP, which offers a Part D drug plan, indicated it still supports reimportation legislation as a benefit for non-Medicare patients. The Canadian mail-order provider ADVCare Pharmacy disputed the AARP report as circumstantial and misleading because it was compared with one or two Rx plans for only five patients.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.